Profile
Åsa Kornfeld currently works at Navamedic ASA, as Director from 2023, Arcede Pharma AB, as Director from 2022, Aptahem AB, as Director, and Gabather AB, as Director from 2023.
Ms. Kornfeld also formerly worked at Sensidose AB, as Director.
Ms. Kornfeld received her graduate degree from Université de Bordeaux and undergraduate degree from the University of Lund.
Åsa Kornfeld active positions
| Companies | Position | Start |
|---|---|---|
| ARCEDE PHARMA AB | Director/Board Member | 01/01/2022 |
| APTAHEM AB | Director/Board Member | - |
| NAVAMEDIC ASA | Director/Board Member | 01/06/2023 |
| GABATHER AB | Director/Board Member | 30/06/2023 |
Former positions of Åsa Kornfeld
| Companies | Position | End |
|---|---|---|
| SENSIDOSE AB | Director/Board Member | - |
Training of Åsa Kornfeld
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Université de Bordeaux
Université de Bordeaux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Navamedic ASA
Navamedic ASA Medical DistributorsDistribution Services Operates as pharmaceutical company | Distribution Services |
Sensidose AB
Sensidose AB Electronic Equipment/InstrumentsElectronic Technology Develops innovative system for individualized dosing of tablet | Electronic Technology |
Arcede Pharma AB
Arcede Pharma AB Miscellaneous Commercial ServicesCommercial Services Develops drug candidates for chronic obstructive pulmonary disease and severe asthma | Commercial Services |
Gabather AB
Gabather AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops mental health drugs | Health Technology |
Aptahem AB
Aptahem AB Pharmaceuticals: MajorHealth Technology Engages in the pharmaceutical businesses, which research and develops medicines for treating and preventing diseases caused by blockage of blood vessels, such as deep vein thrombosis, stroke and heart failure | Health Technology |
- Stock Market
- Insiders
- Åsa Kornfeld
















